fda compounding semaglutide crackdown october 2025 September 2, 2025: U.S. restrictions have stemmed a flood of compounded and tirzepatide – Partnership for Safe Medicines FDA Intensifies Crackdown on GLP-1

Current GLP-1 medications include: Wegovy (semaglutide) licensed for weight loss Ozempic and Rybelsus (semaglutide) licensed for type 2 diabetes Mounjaro (tirzepatide) licensed for both diabetes and weight loss Liraglutide varies by brand

Unlike currently approved weight loss medications, retatrutide works as a triple agonist, meaning it targets three different hormone receptors: GIP, GLP-1, and glucagon receptors

While theres no evidence of any GLP-1 medications interacting with alcohol, many people reported that they had a decreased desire to consume alcoholic beverages while taking a GLP-1 medication, so this may be an easier adjustment than youd expect

GLP-1 Weight Loss Program Affordable weight loss solutions with custom GLP-1 compounds tailored to your unique needs

More importantly, it was estimated that approximately 45% of HFpEF patients had DM

So sorry about that